APOC3, which plays a multifaceted role in triglyceride homeostasis, has been reported to exacerbate early-stage diabetic nephropathy by activating the renal TLR2/NF-κB pathway (Wang et al., 2021). This evidence concerns the gene NFKB1 and diabetic kidney disease.